Gd(III)‐EPTPAC16, a new self‐assembling potential liver MRI contrast agent: in vitro characterization and in vivo animal imaging studies
Authors:
- Maria I. M. PrataMPMaria I. M. Prata
- João P. AndréJAJoão P. André
- José A. MartinsJMJosé A. Martins
- Éva TóthÉTÉva Tóth
- Maria L. García‐MartínMaria L. García‐Martín
- Tiago B. RodriguesTRTiago B. Rodrigues
- Pilar López‐LarrubiaPilar López‐Larrubia
- Sebastián CerdánSCSebastián Cerdán
- Carlos F. G. C. GeraldesCarlos F. G. C. Geraldes
- 10 August 2007
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 21 (4) , 322-336
Abstract
The recently reported amphiphilic chelate, [Gd(EPTPAC16)(H2O)]2−, forms supramolecular aggregates in aqueous solution by self‐assembly of the monomers with a relaxometrically determined critical micellar concentration (CMC) of 0.34 mM. The effect of sonication on the aggregate size was characterized by dynamic light scattering and relaxometry, indicating the presence of premicellar aggregates and an overall decrease in aggregate size and polydispersity upon sonication, slightly below the CMC. {[153Sm](EPTPAC16)(H2O)}2− radiotracer was evaluated in vivo from γ scintigraphy and biodistribution in Wistar rats. It was found to depend strongly on the sample concentration, below or above the CMC, and its sonication, in a way that correlates with the effect of the same factors on the size of the aggregates formed in solution. Below CMC, the very large aggregates of the [153Sm]3+‐labeled chelate were persistently and mainly taken up by the lungs, and also by the macrophage‐rich liver and spleen. Sonication of this solution led to loss of the lung uptake. Above CMC, the metal chelate was mainly taken up by the liver, with very little uptake by the spleen and lungs. In vivo, dynamic contrast‐enhanced (DCE)‐MRI evaluation of the micellar [Gd(EPTPAC16)(H2O)]2− compound in Wistar rats showed a persistent hepatic positive‐contrast effect in T1‐weighted images, qualitatively similar to the clinically established GdIII‐based hepatobiliary‐selective agents. No enhancement effect was observed in the lungs because of the scarcity of mobile protons in this organ, despite the scintigraphic evidence of significant lung retention of the [153Sm]3+‐labeled chelate at concentrations below the CMC. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 62 references indexed in Scilit:
- Low-Density Lipoprotein Nanoparticles as Magnetic Resonance Imaging Contrast AgentsNeoplasia, 2006
- Molecular Imaging and Therapy: New Paradigms for 21st Century Medicine2006
- Lanthanide(III) Chelates of DTPA Bis(amide) Glycoconjugates: Potential Imaging Agents Targeted at the Asyaloglycoprotein ReceptorEuropean Journal of Inorganic Chemistry, 2005
- Gadolinium DTPA‐Monoamide Complexes Incorporated into Mixed Micelles as Possible MRI Contrast AgentsEuropean Journal of Inorganic Chemistry, 2004
- Physicochemical Properties of Mixed Micellar Aggregates Containing CCK Peptides and Gd Complexes Designed as Tumor Specific Contrast Agents in MRIJournal of the American Chemical Society, 2004
- Phantom and animal studies of a new hepatobiliary agent for MR imaging: Comparison of Gd-DTPA-DeA with Gd-EOB-DTPAJournal of Magnetic Resonance Imaging, 2003
- Metal Complexes as MRI Contrast Enhancement Agents2003
- From monomers to micelles: investigation of the parameters influencing proton relaxivityJBIC Journal of Biological Inorganic Chemistry, 2002
- Conductivity and Relative Permittivity of Sodium n-Dodecyl Sulfate and n-Dodecyl Trimethylammonium BromideJournal of Chemical & Engineering Data, 1999
- Tuning water-exchange rates on (carboxymethyl)iminobis(ethylenenitrilo)tetraacetate (dtpa)-type gadolinium(III) complexesJ. Chem. Soc., Dalton Trans., 1997